Skip to main navigation Skip to search Skip to main content

Expression of CD28, CTLA4, CD80, and CD86 molecules in patients with autoimmune rheumatic diseases: Implications for immunotherapy

  • P. P. Sfikakis*
  • , C. S. Via
  • *Corresponding author for this work

Research output: Contribution to journalEditorial

34 Scopus citations
Original languageEnglish
Pages (from-to)195-198
Number of pages4
JournalClinical Immunology and Immunopathology
Volume83
Issue number3
DOIs
StatePublished - 1997

Fingerprint

Dive into the research topics of 'Expression of CD28, CTLA4, CD80, and CD86 molecules in patients with autoimmune rheumatic diseases: Implications for immunotherapy'. Together they form a unique fingerprint.

Cite this